Principles of Precision Hormone Therapy
Springer International Publishing (Verlag)
978-3-031-89649-1 (ISBN)
Hormones such as estrogens, testosterone, thyroid hormones, and growth hormone are essential for metabolic homeostasis in all cells. However, their levels decline with age, contributing to aging and chronic disease. Proper hormone therapy can help delay the onset of age-related diseases, yet there is currently no authoritative, up-to-date resource on precision hormone optimization for healthy aging. Current standard of care textbooks rely on outdated concepts, while books aimed at non-specialist clinicians and patients are often written by non-experts and lack a solid scientific foundation.
This book bridges that gap by presenting cutting-edge scientific data and insights from leading academic and private practice experts on the role of hormone optimization in healthy aging. It dispels common misconceptions about hormone therapy risks and highlights the proven benefits of precision hormone treatments. Drawing on both scientific evidence and clinical experience, it explores the distinctions between synthetic hormones and bioidentical, physiological hormones. Designed to challenge conventional thinking, this book aims to inspire discussion and further research among scientists and healthcare practitioners. It is an essential resource for basic and clinical researchers seeking translational knowledge on hormone therapy, as well as clinicians looking to integrate hormone optimization into their practice.
Dr. Franck Mauvais-Jarvis is a physician-scientist with clinical training in Medicine and Endocrinology from the University of Paris V School of Medicine in France, and a PhD in Biochemistry and Molecular Biology from the University of Paris XI School of Medicine. He is currently the Price-Goldsmith Professor and Professor of Medicine (Endocrinology and Metabolism) at Tulane University. Dr. Mauvais-Jarvis is Director of the Tulane Center of Excellence in Sex-Based Biology and Medicine, as well as the Director of the Diabetes Discovery Research and Sex-Based Medicine Laboratory. His research program focuses on basic research, translational approaches and clinical studies to understand the role of biological sex and sex hormones in diabetes and obesity, with the goal of developing sex-based therapies. He also studies the role of biological sex, diabetes, and obesity in COVID-19 severe outcomes.
1. Introduction.- Part I: Menopausal hormone therapy in women.- 2. Consequences of oestradiol deficiency in menopausal women.- 3. Menopausal hormone therapy and prevention of chronic disease.- 4. Menopausal hormone therapy in primary care. Benefits, risks, and how to tailor the dose.- 5. Menopausal hormone therapy and prevention of cardiovascular disease.- 6. Menopausal hormone therapy and diabetes.- 7. Menopausal hormone therapy and cognition: An opportunity for precision medicine.- 8. Menopause hormone therapy in chronic auto-immune, pulmonary, and neurodegenerative diseases.- 9. Current concepts in menopausal hormone therapy and breast cancer.- 10. Progesterone and progestins in women s health.- 11. Testosterone therapy in menopausal women with sexual dysfunction: 1940-2024.- 12. Testosterone therapy and metabolic health in menopausal women.- Part II. Testosterone therapy in hypogonadal men.- 13. Impact of testosterone deficiency and therapy on men s health.- 14. History of testosterone therapy in men with testosterone deficiency.- 15. Testosterone therapy in men with functional hypogonadism.- 16. Male testosterone deficiency and therapy in primary care.- 17. Long-term effects of testosterone therapy in men with testosterone deficiency.- 18. Hypogonadism in men with obesity and diabetes.- 19. Testosterone therapy and prevention of type 2 diabetes in men with hypogonadism.- 20. Testosterone therapy and cardiovascular health.- 21. Testosterone therapy and the prostate.- 22. Benefits of testosterone therapy on mood and well-being.- 23.
| Erscheinungsdatum | 18.07.2025 |
|---|---|
| Zusatzinfo | XI, 487 p. 22 illus., 20 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| Naturwissenschaften ► Biologie | |
| Schlagworte | Ageing • aging • bioidentical physiological hormones • Chronic Disease • Estrogen • Hormone deficiency • hormone optimization • HRT • Hypothyroidism • menopause • Progestogen • synthetic hormone • Testosterone |
| ISBN-10 | 3-031-89649-1 / 3031896491 |
| ISBN-13 | 978-3-031-89649-1 / 9783031896491 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
